Abstract:Background: Despite the fact that the alimentary tract is part of the body's first line of defense against orally ingested xenobiotica, little is known about the distribution and expression of cytochrome P450 (CYP) enzymes in human colon. Therefore, expression and protein levels of four representative CYPs (CYP2C(8), CYP2E1, CYP3A4, and CYP3A5) were determined in human colon mucosa biopsies obtained from ascending, descending and sigmoid colon. Methods: Expression of CYP2C, CYP2E1, CYP3A4, and CYP3A5 mRNA in colon mucosa was determined by RT-PCR. Protein concentration of CYPs was determined using Western blot methods. Results: Extensive interindividual variability was found for the expression of most of the genes. However, expression of CYP2C mRNA levels were significantly higher in the ascending colon than in the sigmoid colon. In contrast, mRNA levels of CYP2E1 and CYP3A5 were significantly lower in the ascending colon in comparison to the descending and sigmoid colon. In sigmoid colon protein levels of CYP2C8 were significantly higher by ~73% than in the descending colon. In contrast, protein concentration of CYP2E1 was significantly lower by ~81% in the sigmoid colon in comparison to the descending colon. Conclusion: The current data suggest that the expression of CYP2C, CYP2E1, and CYP3A5 varies in different parts of the colon. Background Throughout the last decades drug metabolism in the alimentary tract has received growing attention as part of the body's first line of defense against orally ingested harmful xenobiotica. Most xenobiotic compounds require an enzymatic activation to form a carcinogen or toxicant. The reactive intermediates resulting form enzymatic drug metabolism are often unstable and therefore are unlikely to be transported from the liver to other tissues to exert toxicity. Therefore, the chemical toxicity found in extrahepatic tissue often results from cellular metabolic activities in the organ. However, knowledge on the variability and regulation of expression of drug metabolizing enzymes in the human gastrointestinal tract and particularly the large intestine is poor in comparison with the "classical" drug metabolizing organs (e.g. liver). Published: 27 October 2005 BMC Clinical Pharmacology 2005, 5:4 doi:10.1186/1472-6904-5-4 Received: 03 May 2005 Accepted: 27 October 2005 This article is available from: http://www.biomedcentral.com/1472-6904/5/4 © 2005 Bergheim et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In vitro effects of growth hormone on the number and activity of ribosomes engaged in protein synthesis in the isolated rat diaphragm.

Verrucous hemangioma. A clinicopathologic study of 21 cases.

Danish University Colleges Distribution of cytochrome P 450 2 C , 2 E 1 , 3 A 4 , and 3 A 5 in human colon mucosa

Efficacy of Intralesional Candida Antigen Versus Measles, Mumps, and Rubella Vaccine Versus Topical Podophyllin in Treatment of Resistant Genital Warts

Evidence behind the WHO guidelines: hospital care for children: what is the evidence that BCG vaccination should not be used in HIV-infected children?

Intralesional Injection of Purified Protein Derivative Versus Candida Antigen in Treatment of Genital Warts

Topical Treatment of All-Trans Retinoic Acid Cream Combined with Penciclovir Cream for Verruca Plana: A Multiple Centre,double-Blind and Control Study

Immunotherapy with Intralesional Vit D injection in Recalcitrant wart at a Tertiary Care Center: A Descriptive Cross sectional Study

Intralesional injection of tuberculin purified protein derivative (PPD) versus measles, mumps, and rubella (MMR) vaccine in treatment of molluscum contagiosum: a comparative study

Poster presentationsBH07 Intralesional vitamin D as immunotherapy for palmoplantar and periungual warts: how effective is it?

Intralesional acyclovir versus intralesional Hepatitis-B vaccine in treatment of resistant plantar warts: a randomized controlled trial

Comparative Analysis of Intralesional Immunotherapy and Conventional Treatments for Non-Genital Warts: A Systematic Review and Network Meta-Analysis

Application of cantharidin, retinoic acid cream and salicylic acidy in multiple palmoplantar warts

Autoinoculation Therapy for the Treatment of Widespread Cutaneous Warts

Verrulyse Methionine® as Monotherapy in Children and Adolescents With Common Warts

[Fifty-three atherosclerotic carotid stenoses in an irradiated environment].

Topical measles-mumps-rubella vaccine in the treatment of recurrent respiratory papillomatosis: results of a preliminary randomized, controlled trial.

Modelling the generic TiO2 memristor with the parasitic components

Energy-Based Devices for the Treatment of Cutaneous Verrucae: A Systematic Review

Intralesional combined furosemide and digoxin in cutaneous warts treatment: A randomized controlled clinical trial

Present management of the lymphomas.